Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,707,631
-$814,127 QoQ
Shares Held
107,259
+48.8% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#281
of 1,413 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$366,045
PutShares
1,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CIBC WORLD MARKET INC. holds $23,874,512 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
107,259 | $7,707,631 | |
| 2 | VTRS |
Viatris Inc
|
265,233 | $4,211,900 | |
| 3 | CRON |
Cronos Group Inc.
|
1,383,299 | $3,845,571 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
92,543 | $3,135,356 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
62,348 | $2,161,605 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,419 | $768,856 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
147,267 | $726,026 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
3,258 | $549,103 |
All Filings in ZTS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,707,631 | 107,259 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,521,758 | 72,090 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,247,496 | 121,185 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $22,007,259 | 150,405 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $22,481,128 | 144,156 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,740,389 | 144,187 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $26,467,326 | 162,446 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $22,013,855 | 112,672 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,720,913 | 113,757 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $21,372,915 | 126,310 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $24,879,672 | 126,056 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $21,770,639 | 125,133 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $21,781,981 | 126,485 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,604,577 | 129,804 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,322,739 | 111,380 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $16,434,980 | 110,830 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $22,971,895 | 133,643 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $30,699,623 | 162,785 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $37,847,100 | 155,092 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $366,045 | 1,500 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $29,717,980 | 153,075 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $28,095,633 | 150,760 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $24,953,650 | 158,456 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $29,636,581 | 179,073 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $32,430,049 | 196,106 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $26,565,752 | 193,854 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $23,998,285 | 203,911 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||